What is a truly innovative drug? New definition from the International Society of drug bulletins;Qu'est-ce qu'un médicament véritablement novateur? Nouvelle définition de l'International Society of drug bulletins

Canadian Family Physician

Volumn 48, Issue SEPT., 2002, Pages 1413-1415

  Kopp, Christophe ^a  

^a International Society Drug Bulletins   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG; PLACEBO;

CLINICAL TRIAL; DEVELOPED COUNTRY; DRUG ADMINISTRATION ROUTE; DRUG APPROVAL; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; DRUG INDUSTRY; DRUG INFORMATION; DRUG PACKAGING; DRUG SAFETY; DRUG USE; EDITORIAL; EVIDENCE BASED MEDICINE; GOVERNMENT; HEALTH CARE SYSTEM; HEALTH PRACTITIONER; HUMAN; INTERMETHOD COMPARISON; MEDICAL DECISION MAKING; MEDICAL ETHICS; MEDICAL LITERATURE; MEDICAL SOCIETY; METHODOLOGY; PATIENT CARE; PHARMACEUTICAL CARE; PHARMACIST; PHYSICIAN; POSTMARKETING SURVEILLANCE; PRESCRIPTION; RISK BENEFIT ANALYSIS;

DRUG AND NARCOTIC CONTROL; DRUG EVALUATION; DRUG INFORMATION SERVICES; DRUG THERAPY; DRUGS, INVESTIGATIONAL; HUMANS; TECHNOLOGY, PHARMACEUTICAL;

EID: 0036750118     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (3)

1. EU Commission. Explanatory memorandum, COM (2001) 404 final. Brussels, Belg: EU Commission; 2001.
2. International Society of Drug Bulletins. ISDB Declaration on therapeutic advance in the use of medicines. Paris, France: International Society of Drug Bulletins; 2001. Available at: www.isdbweb.org. Accessed 2002 July 24.
3. World Medical Association; October 2000; Section C, clause 29. Available at: www.wma.net. Accessed 2002 July 24.